Clearside Biomedical Inc.

1.48-0.0700-4.52%Vol 177.64K1Y Perf -34.87%
May 18th, 2022 16:00 DELAYED
BID1.42 ASK1.51
Open1.54 Previous Close1.55
Pre-Market- After-Market1.51
 - -  0.03 2.03%
Target Price
10.80 
Analyst Rating
Strong Buy 1.40
Potential %
629.73 
Finscreener Ranking
★★★★+     58.27
Insiders Trans % 3/6/12 mo.
-/-100/-80 
Value Ranking
★★★★+     60.04
Insiders Value % 3/6/12 mo.
-/-100/-81 
Growth Ranking
★★★★★     77.95
Insiders Shares Cnt. % 3/6/12 mo.
-/-100/-89 
Income Ranking
 —    -
Price Range Ratio 52W %
2.80 
Earnings Rating
Strong Buy
Market Cap89.02M 
Earnings Date
11th May 2022
Alpha-0.00 Standard Deviation0.33
Beta2.16 

Today's Price Range

1.451.59

52W Range

1.307.73

5 Year PE Ratio Range

-5.50-1.50

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
6.90%
1 Month
-19.69%
3 Months
0.00%
6 Months
-65.48%
1 Year
-34.87%
3 Years
27.05%
5 Years
-81.70%
10 Years
-

TickerPriceChg.Chg.%
CLSD1.48-0.0700-4.52
AAPL140.82-8.4200-5.64
GOOG2 248.02-86.0100-3.69
MSFT254.08-12.1200-4.55
XOM90.65-1.4600-1.59
WFC42.11-1.6000-3.66
JNJ175.50-3.3200-1.86
FB192.24-10.3800-5.12
GE75.20-1.2000-1.57
JPM120.09-2.0900-1.71
Financial StrengthValueIndustryS&P 500US Markets
8.70
9.10
0.01
0.02
-
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
-
-2.10
-1.50
-58 945.60
25.40
RevenueValueIndustryS&P 500US Markets
29.54M
0.49
583.57
319.29
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.03-0.13-333.33
Q04 20210.090.31244.44
Q03 2021-0.09-0.0811.11
Q02 2021-0.12-0.118.33
Q01 2021-0.08-0.13-62.50
Q04 2020-0.13-0.14-7.69
Q03 2020-0.14-0.0564.29
Q02 2020-0.13-0.130.00
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.0455.56Positive
9/2022 QR-0.118.33Positive
12/2022 FY-0.2728.95Positive
12/2023 FY-0.4416.98Positive
Next Report Date-
Estimated EPS Next Report-0.03
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume177.64K
Shares Outstanding60.15K
Shares Float54.44M
Trades Count962
Dollar Volume270.39K
Avg. Volume542.11K
Avg. Weekly Volume285.60K
Avg. Monthly Volume310.55K
Avg. Quarterly Volume1.03M

Clearside Biomedical Inc. (NASDAQ: CLSD) stock closed at 1.55 per share at the end of the most recent trading day (a 6.16% change compared to the prior day closing price) with a volume of 524.75K shares and market capitalization of 89.02M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 33 people. Clearside Biomedical Inc. CEO is George Lasezkay.

The one-year performance of Clearside Biomedical Inc. stock is -34.87%, while year-to-date (YTD) performance is -43.64%. CLSD stock has a five-year performance of -81.7%. Its 52-week range is between 1.3001 and 7.73, which gives CLSD stock a 52-week price range ratio of 2.80%

Clearside Biomedical Inc. currently has a PE ratio of 141.00, a price-to-book (PB) ratio of 2.23, a price-to-sale (PS) ratio of 2.97, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of 1.24%, a ROC of 1.52% and a ROE of 1.63%. The company’s profit margin is 25.40%, its EBITDA margin is -1.50%, and its revenue ttm is $29.54 Million , which makes it $0.49 revenue per share.

Of the last four earnings reports from Clearside Biomedical Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.03 for the next earnings report. Clearside Biomedical Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Clearside Biomedical Inc. is Strong Buy (1.4), with a target price of $10.8, which is +629.73% compared to the current price. The earnings rating for Clearside Biomedical Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Clearside Biomedical Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Clearside Biomedical Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 12.42, ATR14 : 0.15, CCI20 : -58.83, Chaikin Money Flow : -0.09, MACD : -0.14, Money Flow Index : 49.55, ROC : 1.31, RSI : 42.89, STOCH (14,3) : 59.67, STOCH RSI : 1.00, UO : 54.21, Williams %R : -40.33), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Clearside Biomedical Inc. in the last 12-months were: Charles A. Deignan (Sold 14 571 shares of value $49 248 ), George M. Lasezkay (Sold 23 132 shares of value $74 450 ), Nancy J. Hutson (Buy at a value of $17 040), Thomas Ciulla (Sold 11 610 shares of value $35 661 ), William D. Humphries (Option Excercise at a value of $3 409)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (80.00 %)
4 (80.00 %)
4 (80.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (20.00 %)
1 (20.00 %)
1 (20.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.40
Strong Buy
1.40
Strong Buy
1.40

Clearside Biomedical Inc.

Clearside Biomedical Inc is the United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision.

CEO: George Lasezkay

Telephone: +1 678 270-3631

Address: 900 North Point Parkway, Alpharetta 30005, GA, US

Number of employees: 33

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

50%50%

Bearish Bullish

58%42%

Bearish Bullish

62%38%

TipRanks News for CLSD

Thu, 12 May 2022 10:45 GMT Analysts Are Bullish on Top Healthcare Stocks: Clearside Biomedical (CLSD), BiomX (PHGE)

- TipRanks. All rights reserved.

Thu, 12 May 2022 09:45 GMT Clearside Biomedical (CLSD) Receives a Hold from Needham

- TipRanks. All rights reserved.

Thu, 12 May 2022 04:25 GMT Analysts Opinions Are Mixed on These Healthcare Stocks: Concert Pharma (CNCE), Clearside Biomedical (CLSD) and Turning Point Therapeutics (TPTX)

- TipRanks. All rights reserved.

Tue, 15 Mar 2022 22:38 GMT Clearside Stock Is up Over 80% In Three Trading Days. How Much Higher Can It Go

- TipRanks. All rights reserved.

Fri, 11 Mar 2022 11:27 GMT Clearside Biomedical (CLSD) Gets a Buy Rating from H.C. Wainwright

- TipRanks. All rights reserved.

News

Stocktwits